Prognostic impact on survival of an unsuccessful conventional cytogenetic study in patients with myelodysplastic syndromes (MDS)

被引：2
|
作者：
Cervera, J. [1 ]
Sole, F.
Haase, D.
Luno, E.
Such, E.
Nomdedeu, B.
Costa, D.
Bernal, T.
Vallespi, T.
Bueno, J.
Pedro, C.
Mallo, M.
Ardanaz, M. T.
Calasanz, M. J.
del Canizo, C.
Hernandez-Rivas, J. M.
Schanz, J.
Steidl, C.
Hildebrandt, B.
Carbonell, F.
Orero, M.
Ramos, F.
Marco, V.
Tormo, M.
Gomez, V.
Andreu, R.
Xicoy, B.
Amigo, M. L.
Munoz, J. A.
Bonanad, S.
Arrizabalaga, B.
Senent, M. L.
Germing, U.
Sanz, G. F.
机构：
[1] Univ Gottingen, D-3400 Gottingen, Germany
来源：
LEUKEMIA RESEARCH | 2009年 / 33卷
关键词：
D O I：
10.1016/S0145-2126(09)70110-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S75 / S76
页数：2
相关论文
共 50 条
  • [31] Pregnancy in patients with myelodysplastic syndromes (MDS)
    Volpicelli, P.
    Latagliata, R.
    Breccia, M.
    Carmosino, I.
    Stefanizzi, C.
    Napoleone, L.
    Vozella, F.
    Levi, A.
    Natalino, E.
    Alimena, G.
    LEUKEMIA RESEARCH, 2008, 32 (10) : 1605 - 1607
  • [32] PROGNOSTIC VALUE OF THE FAB CLASSIFICATION FOR MYELODYSPLASTIC SYNDROMES (MDS)
    AUL, C
    FISCHER, JT
    HORSTKOTTE, D
    SCHNEIDER, W
    BLUT, 1984, 49 (03): : 246 - 246
  • [33] Revised IPSS cytogenetic categories and WHO classification allow a better prognostic definition of patients with de novo myelodysplastic syndromes (MDS)
    Bernasconi, P.
    Klersy, C.
    Boni, M.
    Cavigliano, P. M.
    Calatroni, S.
    Giardini, I.
    Rocca, B.
    Zappatore, R.
    Caresana, M.
    Dambruoso, I.
    Lazzarino, M.
    Bernasconi, C.
    LEUKEMIA RESEARCH, 2007, 31 : S98 - S99
  • [34] Need of transfusions, treatment and survival of patients with Myelodysplastic Syndromes (MDS): Update of the outpatient MDS registry
    Steinmetz, H. T.
    Boettger, I
    Lathan, B.
    Sauer, A.
    Severin, K.
    Germing, U.
    Schmitz, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 234 - 234
  • [35] Standards and Impact of Hematopathology in Myelodysplastic Syndromes (MDS)
    Valent, Peter
    Orazi, Attilio
    Buesche, Guntram
    Schmitt-Graeff, Annette
    George, Tracy I.
    Sotlar, Karl
    Streubel, Berthold
    Beham-Schmid, Christine
    Cerny-Reiterer, Sabine
    Krieger, Otto
    van de Loosdrecht, Arjan
    Kern, Wolfgang
    Ogata, Kiyoyuki
    Wimazal, Friedrich
    Csomor, Judit
    Varkonyi, Judit
    Sperr, Wolfgang R.
    Werner, Martin
    Kreipe, Hans
    Horny, Hans-Peter
    ONCOTARGET, 2010, 1 (07) : 483 - 496
  • [36] Impact of sleep disturbance in myelodysplastic syndromes (MDS)
    Solis, Roxanne M.
    Cronin, Angel
    Watts, Corey D.
    Steensma, David P.
    Stone, Richard M.
    DeAngelo, Daniel J.
    Owens, Robert L.
    Wadleigh, Martha
    Abel, Gregory Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)
  • [37] Prognostic Factors for Post-Transplant Outcomes in Patients with Myelodysplastic Syndromes (MDS)
    Bejanyan, Nelli
    Maciejewski, Jaroslaw P.
    Rybicki, Lisa
    O'Keefe, Christine L.
    Nyatanga, Nolyn
    Tench, Shawnda
    Sekeres, Mikkael A.
    Advani, Anjali S.
    Saunthararajah, Yogen
    Duong, Hien
    Sobecks, Ronald
    Kalaycio, Matt
    Bolwell, Brian J.
    Copelan, Edward A.
    BLOOD, 2011, 118 (21) : 881 - 881
  • [38] Frequency and Prognostic Significance of Cytogenetic Abnormalities in 1269 Patients with Therapy-Related Myelodysplastic Syndrome - a Study of the International Working Group (IWG-PM) for Myelodysplastic Syndromes (MDS)
    Kuendgen, Andrea
    Tuechler, Heinz
    Nomdedeu, Meritxell
    Haase, Detlef
    Garcia-Manero, Guillermo
    Komrokji, Rami S.
    Sole, Francesc
    Sekeres, Mikkael A.
    Della Porta, Matteo Giovanni
    List, Alan F.
    Cazzola, Mario
    DeZern, Amy E.
    Roboz, Gail J.
    Steensma, David P.
    de Loosdrecht, Arjan A. van
    Schlenk, Richard F.
    Calvo, Xavier
    Blum, Sabine
    Pereira, Arturo
    Pereira, Arturo
    Valent, Peter
    Costa, Dolors
    Costa, Dolors
    Giagounidis, Aristoteles
    Giagounidis, Aristoteles
    Benlloch, Luis
    Platzbecker, Uwe
    Pedro, Carmen
    Luebbert, Michael
    Cedena, Maria Teresa
    Schanz, Julie
    Machherndl-Spandl, Sigrid
    Lopez-Pavia, Maria
    Diez-Campelo, Maria
    Baldus, Claudia D.
    de Sola, Montserrat Martinez
    Stauder, Reinhard
    Merchan, Brayan
    Mende, Claudia
    Voso, Maria Teresa
    Voso, Maria Teresa
    Oiartzabal, Itziar
    Oiartzabal, Itziar
    Ganster, Christina
    Cobo, Francesc
    Schroeder, Thomas
    Esteve, Jordi
    Haas, Rainer
    Nomdedeu, Benet
    Greenberg, Peter
    BLOOD, 2016, 128 (22)
  • [39] Phase II study of amifostine in patients with myelodysplastic syndromes (MDS).
    List, AF
    Holmes, H
    Greenberg, PL
    Bennett, JM
    Oster, W
    BLOOD, 1999, 94 (10) : 305A - 305A
  • [40] Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS-CAN prospective study
    Buckstein, Rena
    Wells, Richard A.
    Zhu, Nancy
    Leitch, Heather A.
    Nevill, Thomas J.
    Yee, Karen W. L.
    Leber, Brian
    Sabloff, Mitchell
    St Hilaire, Eve
    Kumar, Rajat
    Geddes, Michelle
    Shamy, April
    Storring, John
    Kew, Andrea
    Elemary, Mohamed
    Levitt, Max
    Lenis, Martha
    Mamedov, Alex
    Zhang, Liying
    Rockwood, Ken
    Alibhai, Shabbir M. H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (01) : 88 - 101
12345